Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location
These findings suggest that PIV may predict recurrence in patients with LCC but not RCC, underscoring the importance of tumor location when using PIV as a colon cancer biomarker.
Authors
- Bin Wu (ORCID: https://orcid.org/0000-0003-0413-6987)
- Junfeng Du (ORCID: https://orcid.org/0000-0002-8482-4271)
- Yi Xiao (ORCID: https://orcid.org/0000-0001-5315-7771)
- Lai Xu (ORCID: https://orcid.org/0000-0002-9444-1733)
- Qianyu Wang (ORCID: https://orcid.org/0000-0001-7048-8847)
- Guannan Zhang (ORCID: https://orcid.org/0000-0001-7733-826X)
- Junyang Lu (ORCID: https://orcid.org/0000-0002-7758-7853)
- Wentao Zhong
- Guole Lin
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.3748/wjg.v30.i33.3823
- Citations
- 15
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.24
Funders
- Peking Union Medical College Hospital